Trial intelligence / Profile preview

Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder

NCT05886582Phase 2Completed

Sponsor
Virginia Commonwealth University
Start
Sep 2023
Primary completion
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of rotigotine in cocaine use disorder (CUD), sponsored by Virginia Commonwealth University. Started Sep 2023; status: completed.

02

Drugs

rotigotine
03

Conditions

cocaine use disorder (CUD)

Beyond the preview

Go deeper on NCT05886582.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05886582.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call